Catalyst Pharmaceuticals, Inc.’s and KYE Pharmaceuticals’ Lawsuit in Canadian Federal Court Quashes the Notice of Compliance (NOC) for Ruzurgi®
– Without an NOC, Ruzurgi® is without a Marketing Authorization in Canada – Matter Remanded Back to Health Canada to…